MiraVista Diagnostics is an Industry Leading Mycology Reference Laboratory

MiraVista Diagnostics is a CLIA and CAP certified mycology reference laboratory (RL) with an exclusive focus on developing and processing diagnostic tests for serious fungal infections. We offer the highest standards in clinical accuracy and sensitivity for detection, monitoring and diagnostic testing for blastomyces dermatitidis, histoplasma capsulatum, cryptococcus, coccidioides, aspergillus and beta-D glucan.

Clinical Laboratory Testing for Serious Fungal Infections

The company was founded in 2002 by the renowned infectious disease scientist, Dr. Lawrence Joseph Wheat, whose groundbreaking research contributions resulted in the development of the first histoplasmosis antigen test in 1986. Today, MiraVista Diagnostics serves the medical and healthcare sectors in the U.S. and Canada processing over 100,000 tests per year for fungal infections. This includes antigen and antibody detection tests for coccidioides (valley fever fungus), aspergillus, histoplasmosis capsulatum, blastomyes dermatitidis and cryptococcus.

MiraVista Diagnostics offers same-day testing, prompt response, fast shipping and direct access to the laboratory’s team of experienced infectious disease specialists that has collectively published more than 1,000 scientific research articles. Clients include large medical research hospitals, healthcare systems and universities as well as large reference labs. Contact us to discuss a fungal infection case, set up a corporate account for high volume testing or order from among MiraVista Diagnostics’ menu of diagnostic screening tests for fungal diseases.

Company News

CDC Investigating Histoplasmosis Outbreak Among Boy Scout Campers in Baton Rouge

At least two Boy Scout campers have been diagnosed with histoplasmosis after staying at Camp Avondale in Baton Rouge, Louisiana.

MiraVista to Receive Economic Incentives from IEDC for Expansion Efforts

Indiana Economic Development Corporation Offers economic incentives to MiraVista Diagnostics. This includes $275,000 in tax credits and $50,000 in training grants to hire additional employees and expand its corporate headquarters and diagnostic laboratory in Indianapolis.

MiraVista Diagnostics is Participating in 2018 ID Week in San Francisco

MiraVista Diagnostics is participating in 2018 ID Week in San Francisco on October 3-7, 2018. Visit us at booth #1032. Representatives from MiraVista will be available to discuss our latest mycology research and menu of diagnostic tests for serious fungal…
READ MORE →

MiraVista is a Sponsor & Poster Presenter @ 2018 MSGERC Biennial Meeting in Big Sky, Montana

MiraVista Diagnostics is a sponsor and poster presenter at the 2018 Biennial Meeting of the Mycoses Study Group Education and Research Consortium (MSGERC) in Big Sky, Montana on September 25-28, 2018. Poster: Largest Study of Histoplasma Meningitis Debunks Assumptions of…
READ MORE →

MiraVista Diagnostics Supports 2018 Fungal Disease Awareness Week

August 13-17 is 2018 Fungal Disease Awareness Week. CDC and partners have organized this week to highlight the importance of recognizing serious fungal diseases early enough in the course of a patient’s illness to provide life-saving treatment. MiraVista Diagnostics supports…
READ MORE →

Visit MiraVista at ASM Microbe 2018 in Atlanta

MiraVista Diagnostics is exhibiting at ASM Microbe 2018 in Atlanta on June 7-11, 2018. Please stop by our booth to talk with one of our team members about diagnostic options for serious fungal infections. For more information about ASM Microbe…
READ MORE →

ORDER TESTS
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo